Advertisements



Axsome reports Duke University completed analysis of Phase 2 trial of AXS-05

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Spring Bank Pharmaceuticals Reports First Quarter 2019 Financial and Operational Results and Provides Corporate Update

ACHIEVE trial completed – inarigivir HBsAg reduction comparable to interferon but with significantly better tolerability profile Phase 2 co-administration study of inarigi.....»»

Category: earningsSource: benzingaApr 29th, 2019

Mallinckrodt reports retrospective analysis on Phase 3 REVERSE trial data at ILC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018

Initiated a Phase 1 trial of SRF231, a fully human antibody targeting CD47 Completed upsized initial public offering and concurrent private placement raising a t.....»»

Category: earningsSource: benzingaMay 29th, 2018

Oragenics reports interim safety analysis results from Phase 2 AG013 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 30th, 2018

AC Immune reports initial interim data from Phase 1b trial of ACI-24 vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2019

AC Immune reports initial interim data from Phase 1b trial of ACI-24 vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2019

Biohaven reports "positive" results from Phase 3 rimegepant clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2019

Duke’s new Chinese campus sits atop a manmade lake

As part of Duke University’s 200-acre global campus in Kunshan, China, the 30-acre first phase of Duke Kunshan University Campus includes five buildings that sit atop a manmade lake and are interconnected by low bridges and seasonal plazas......»»

Category: realestateSource: bdcnetworkJul 3rd, 2019

Replimune Reports Fourth Fiscal Quarter and Year 2019 Financial Results and Provides Corporate Update

RP1: Initiated Phase 2 part of Phase 1/2 clinical trial.....»»

Category: earningsSource: benzingaJun 28th, 2019

Entera Bio Reports First Quarter 2019 Financial Results and Operating Update

Phase 2b Study for oral PTH in osteoporosis to begin by mid-year 2019 Completed Part 2 of a Phase 2 PK/PD study in hypoparathyroidism patients. Data processing and statistical analysi.....»»

Category: earningsSource: benzingaJun 27th, 2019

Acasti Pharma Provides Fiscal 2019 Year-End Business Update

Both Phase 3 TRILOGY studies at 100% randomization >60% of patients have completed the 6-month trial Release of topline results r.....»»

Category: earningsSource: benzingaJun 26th, 2019

Axsome Therapeutics initiates GEMINI Phase 3 trial of AXS-05

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2019

Epizyme reports updated data from tazemetostat Phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 21st, 2019

Aclaris Therapeutics reports "positive" results from Phase 2 trial of ATI-502

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2019

AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 16th, 2019

Bristol-Myers reports updated efficacy data from Phase 2 Empliciti combo trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

Taiwan Liposome announces part 1 analysis of Phase 2 TLC590 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

Amgen reports serious adverse events in Phase 1 trial of myeloma treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 5th, 2019

Epizyme reports new data from Phase 2 Trial of Tazemetostat at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2019

BioPharmX reports last patient visit in Phase 2b papulopustular rosacea trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2019